Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soohyeon Lee

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Molecular Cancer Research : MCR|June 17, 2010
Matrix metalloproteinase-1 expression can be upregulated through mitogen-activated protein kinase pathway under the influence of human epidermal growth factor receptor 2 synergized with estrogen receptorHae Hyun Jung, Yeon Hee Park, Hyun Jung Jun, et al.
BMJ Open|May 1, 2024
Evaluating the effect of a mobile-based symptom monitoring system for improving physical function in patients with cancer during chemotherapy: study protocol for a multicentre randomised controlled trialMangyeong Lee, Danbee Kang, Yesol Um, et al.
Frontiers in Pharmacology|January 28, 2021
Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell KillingChan Gyu Lee, TaeEun Kim, Sungyoul Hong, et al.
Cancers|June 2, 2021
Clinical Implication of Liquid Biopsy in Colorectal Cancer Patients Treated with MetastasectomySoohyeon Lee, Young-Soo Park, Won-Jin Chang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 23, 2013
Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumorsHan Sang Kim, Sang Joon Shin, Sang Cheol Kim, et al.
Gynecologic Oncology|December 3, 2014
Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10Sook Hee Hong, Soohyeon Lee, Hoon-Gu Kim, et al.
Cancers|November 10, 2020
Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)Soohyeon Lee, Seock-Ah Im, Gun Min Kim, et al.
Neuro-Oncology|June 14, 2012
Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogramHee Kyung Ahn, Soohyeon Lee, Yeon Hee Park, et al.
Lancet (London, England)|October 23, 2025
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trialJ Randolph Hecht, Young Suk Park, Josep Tabernero, et al.
International Journal of Clinical Oncology|June 15, 2026
Erlotinib plus bevacizumab in EGFR-amplified metastatic solid tumors: results from the KOSMOS I, II study of molecular profiling-guided therapy in advanced cancersJiwon Lee, Jongmin Sim, Yun-Gyoo Lee, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Molecular Cancer Research : MCR|June 17, 2010
Matrix metalloproteinase-1 expression can be upregulated through mitogen-activated protein kinase pathway under the influence of human epidermal growth factor receptor 2 synergized with estrogen receptorHae Hyun Jung, Yeon Hee Park, Hyun Jung Jun, et al.
BMJ Open|May 1, 2024
Evaluating the effect of a mobile-based symptom monitoring system for improving physical function in patients with cancer during chemotherapy: study protocol for a multicentre randomised controlled trialMangyeong Lee, Danbee Kang, Yesol Um, et al.
Frontiers in Pharmacology|January 28, 2021
Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell KillingChan Gyu Lee, TaeEun Kim, Sungyoul Hong, et al.
Cancers|June 2, 2021
Clinical Implication of Liquid Biopsy in Colorectal Cancer Patients Treated with MetastasectomySoohyeon Lee, Young-Soo Park, Won-Jin Chang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 23, 2013
Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumorsHan Sang Kim, Sang Joon Shin, Sang Cheol Kim, et al.
Gynecologic Oncology|December 3, 2014
Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10Sook Hee Hong, Soohyeon Lee, Hoon-Gu Kim, et al.
Cancers|November 10, 2020
Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)Soohyeon Lee, Seock-Ah Im, Gun Min Kim, et al.
Neuro-Oncology|June 14, 2012
Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogramHee Kyung Ahn, Soohyeon Lee, Yeon Hee Park, et al.
Lancet (London, England)|October 23, 2025
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trialJ Randolph Hecht, Young Suk Park, Josep Tabernero, et al.
International Journal of Clinical Oncology|June 15, 2026
Erlotinib plus bevacizumab in EGFR-amplified metastatic solid tumors: results from the KOSMOS I, II study of molecular profiling-guided therapy in advanced cancersJiwon Lee, Jongmin Sim, Yun-Gyoo Lee, et al.
Pageof 10